Consolidated Company Outline

Company Name Olympus Corporation
Market 1st section of Tokyo Stock Exchange
Stock Code ISIN: JP3201200007
Established October 12, 1919
Director, Representative Executive Officer, President and CEO Yasuo Takeuchi
Head Office Shinjuku Monolith, 3-1 Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 163-0914, Japan

Map

Business Lines Manufacture and sales of precision machineries and instruments
Share Capital 124.60 billion yen (As of March 31, 2021)
Consolidated Revenue 730.5 billion yen (Fiscal year ended March 31, 2021)
Consolidated Headcount 31,653 (As of March 31, 2021)

Share of Revenue by Business Segment

Fiscal year ended March 2021: Consolidated revenue 730.5 billion Yen. Share of revenue by business segment: Endoscopic Solutions 419.5 billion Yen 57.4%, Therapeutic Solutions 206 billion Yen 28.2%, Scientific Solutions 95.9 billion Yen 13.1%, and Other 9.2 billion Yen 1.3%.

Our largest business domain is medical solutions business.
Medical business consist of Endoscopic Solutions and Therapeutic Solutions. They cover nearly 80% of the revenue. Especially, Endoscopic Solutions occupies the largest part.

See Olympus Medical Business for details

Number of Group Companies

Number of Group Companies: 100 (Excluding Olympus Corporation)

Revenue and Operating Profit

Revenue and operating profit, fiscal year ended March: 2017 Revenue 740.6 billion Yen, operating profit 71.2 billion Yen, 2018 Revenue 786.5 billion Yen, operating profit 81 billion Yen, 2019 Revenue 793.9 billion Yen, operating profit 28.3 billion Yen, 2020 Revenue 755.2 billion Yen, operating profit 92.2 billion Yen, 2021 Revenue 730.5 billion Yen, operating profit 80.2 billion Yen,

Note) We split off the imaging business to a special purpose company established by Japan Industrial Partners, Inc. on January 1, 2021. In this regard, imaging division is categorized as a discontinued operation, effective Q2 of FY2021 and figures of FY2020 is restated.

Revenue by Region

Fiscal year ended March 2021: Consolidated revenue 730.5 billion Yen. Japan 123.4 billion Yen 17%, North America 237 billion Yen 32%, Europe 181.2 billion Yen 25%, China 110.3 billion Yen 15%, Asia and Oceania 63.6 billion Yen 9%, Other Region 15 billion Yen 2%.Fiscal year ended March 2021: Consolidated revenue 730.5 billion Yen. Japan 123.4 billion Yen 17%, North America 237 billion Yen 32%, Europe 181.2 billion Yen 25%, China 110.3 billion Yen 15%, Asia and Oceania 63.6 billion Yen 9%, Other Region 15 billion Yen 2%.